|
Independent research & practical ideas for global prosperity
|
|
|
|
Independent research & practical ideas for global prosperity
|
|
January 26, 2010Adult Male Circumcision as an HIV Prevention Tool: Should the Scale Up of an Efficacious Intervention Be Evaluated?Posted by Mead Over in Evaluation, Monitoring, and MeasurementThe results of the three randomized controlled trials (RCTs) of medical adult male circumcision have all agreed. As recently reviewed by the Cochrane Collaboration, male circumcision reduces the odds that a man will become HIV infected by somewhere between 38 % to 66 % over a period of 24 months. Furthermore, the incidence of “adverse events” was deemed low. For an overview of the last five years of findings on male circumcision, see UNAIDS web site on the topic here and here. Wow! A vaccine this efficacious would be cause for celebration. Read More… 13 Comments »January 11, 2010Evaluation, Evaluation Everywhere: IOM Progress on Evaluating the Impact of PEPFARPosted by David Wendt in Evaluation, Monitoring, and Measurement, HIV/AIDS & Infectious Diseases, UncategorizedWithin the beltway and across newspaper headlines, PEPFAR is widely perceived as a very successful US foreign assistance program. Without fail, mentions of PEPFAR’s success all reference the same single measure: currently PEPFAR supports 2.4 million people on ARV treatment. Interestingly, these broad perceptions of success exist despite the fact that, or maybe because, there has never been a systematic evaluation of PEPFAR’s impact. However, that is in the process of changing. In the 2008 re-authorization of PEPFAR, the US Institute of Medicine (IOM) was mandated to evaluate the impact of PEPFAR. This is a monumental task. PEPFAR will have spent around US$60 billion over 10 years, through multiple US government agencies and hundreds of partnering organizations, and across dozens of countries and equally many program areas. The IOM has been tasked with figuring out how this immense initiative has changed the world. Read More… 3 Comments »December 14, 2009Johns Hopkins Makes a New Commitment to Vaccine AccessPosted by Ruth Levine in Evaluation, Monitoring, and MeasurementLet’s think about what decisionmakers in Ministries of Health need to know to make informed choices about what vaccines to introduce into their immunization programs, when and how. The list is long: disease burden, vaccine efficacy, costs and benefits of different introduction strategies (general or high-risk populations? routine or campaign?), financing approaches and more. And the lack of that information, available in a credible and timely way, is one of the barriers to uptake of newer vaccines. Read More… 1 Comment »October 30, 2009Will the New White House Initiative for Rigorous Evaluation Elicit a Response from the U.S. Foreign Assistance Agencies?Posted by Mead Over in Evaluation, Monitoring, and Measurement, UncategorizedThis October 7 memo from Peter Orszag is interesting not only for its emphasis on evaluation, but also for its use of a carrot approach instead of (in addition to?) a stick approach to getting the participation of the various agencies and bureaus of the US government. (Thanks to Mattias Lundberg for flagging this memo for me.) Read More… 2 Comments »October 8, 2009The Power of Demo-GraphicsPosted by Danielle Kuczynski in Evaluation, Monitoring, and Measurement Tags: Demographics and DevelopmentSometimes ‘connecting the dots’ between different ideas in the development discourse can be a challenge. But as Hans Rosling has highlighted through his famous Gapminder presentations at TED, a picture is really worth a thousand blog posts when it can be used to draw connections and emphasize trends that may not otherwise become apparent. A new blog post by Rachel Nugent on Views from the Center examines recent attention to demographic issues in the Economist and draws connections across these pieces with some ‘demo-graphics’ that show long term fertility trends in Sub-Saharan Africa and in rich countries. Comment »November 30, 2004How to win the AIDS battlePosted by Ruth Levine in Evaluation, Monitoring, and Measurement, Global Health, HIV/AIDS & Infectious DiseasesSmart generals study history. The lessons of battles past provide valuable clues about how to win in the future. In the war against AIDS in the developing world we need to study how major successes have been achieved in health programs and how to apply those lessons today. As we are sure to be reminded on World AIDS Day, this Wednesday, the disease has killed 22 million people since 1980, most of them in the prime of their lives. Forty million people around the world are living with AIDS; 70 percent live in sub-Saharan Africa. Last year alone, 5 million more people in developing countries became infected, and 3 million died. Without a major improvement in prevention efforts, within 10 years 45 to 50 million more people will become infected. This is the contour of a war in which winning now looks impossible but losing is unthinkable. Comment » |
|
|
CENTER FOR GLOBAL DEVELOPMENT
1800 Massachusetts Avenue NW, Third Floor
Washington DC 20036
Tel 202.416.4000 | Fax 202.416.4050
|
|
|
Print
Share
